SOURCE: Quture International, Inc.

Quture International, Inc.

April 10, 2014 08:15 ET

Quture (QUTR) Retains Joel Mayersohn of Roetzel & Andress as Corporate Legal Counsel

Company Continues to Prepare for Intended Growth, Expansion and Corporate SEC Filings

DAYTONA BEACH, FL--(Marketwired - Apr 10, 2014) - Quture International, Inc. (OTCQB: QUTR) (Q) today announced retaining Joel D. Mayersohn, JD, a Partner in the firm of Roetzel & Andress practicing in their Fort Lauderdale, Florida office, as new legal counsel to the Company. Mr. Mayersohn will initially focus on collaborating with Q's auditor to file pending the 10-K and 10-Q's as previously announced in the Shareholder Letter and Update. The Company has requested its legal counsel and auditor to examine previously reported but undocumented debt in the Company's previous merger with Techs Loanstar (trading as TCLN), as well as material changes in the condition of the Company and several affiliations in that merger. Mr. Mayersohn will then focus on any legal matters identified in this process, as well as Q's structure and subsidiary relationships. Q has now completed its extensive search process working with its advisors and vendors to identify Mr. Mayersohn and decision to retain legal counsel as the Company prepares for intended growth transitioning from software development to operations and revenue.

Mr. Mayersohn specializes in corporate, securities and business law. He advises a diversified client base in private placement, public offerings, mergers and acquisitions, financing transactions and general securities, as well as corporate law matters. He also has experience in venture capital, going private transactions, bridge loans and pipe financings.

"As Q becomes properly funded to transition to fundamentals with revenue," said Landon Feazell, Chairman & CEO of Quture, "We continue to build our Management Team supported with exceptionally qualified professionals, now including corporate legal counsel. After a diligent search process and a series of meetings with Joel Mayersohn since January, I am extremely pleased for him to commence his legal representation of the Company. Mr. Mayersohn's extensive expertise representing public companies with a diverse clientele, financing transactions, mergers and acquisitions and general securities matters will be a valuable addition to Q and its shareholders. During our discussions of specific initial priorities for his focus, he has already demonstrated insight with logical and practical immediate approaches and experience-based solutions to our legal representation."

About Quture International, Inc.
Quture International (OTCQB: QUTR) ("Q") is the proven and experienced clinical performance and outcome analytics and solutions company in American healthcare. Q's first-to-market clinical intelligence software is the complete solution for healthcare providers, payers, employers, and insurance companies seeking to achieve optimal clinical, financial and operational outcomes. Q's QualOptima Connectivity & Analytics System empowers value-driven, patient-centered, personalized care focused on real-time and predictive patient management and patient safety, with optimal quality demonstrated by outcomes correlated with resource use, revenue and cost. As an Application Partner of InterSystems Corporation, Q's software operates on their HealthShare strategic technology platform to capture, integrate, aggregate, and analyze data transformed to knowledge in Q's innovative second-generation database. InterSystems ( has customers in over 100 countries with 80% of top hospitals in America currently utilizing its technology. Q's core competence and value proposition lies in its embedded evidence-based metrics, clinical content and analytic algorithms developed from over 35 years of measuring performance in hundreds of hospitals, physician organizations and HMO's. 

As the free enterprise solution to improving health and healthcare while reducing costs, Q is positioned through its disruptive technology to become the foremost global provider of value-based clinical intelligence and knowledge solutions. Q is a Nevada corporation based in Daytona Beach, Florida, and trades on the OTC exchange under the symbol 'QUTR.'

Forward Looking Statements: This release contains forward-looking statements, including, without limitation, statements concerning our business and possible or assumed future results of operations. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons including: our ability to continue as a going concern, adverse economic changes affecting markets we serve; competition in our markets and industry segments; our timing and the profitability of entering new markets; greater than expected costs, customer acceptance of our products or difficulties related to our integration of the businesses we may acquire; and other risks and uncertainties as may be detailed from time to time in our public announcements and SEC filings. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and our future results, levels of activity, performance or achievements may not meet these expectations. We do not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in our expectations, except as required by law. There is no assurance that a definitive agreement will be completed.

Contact Information